Pacira BioSciences, Inc.
US ˙ NasdaqGS ˙ US6951271005

SecurityPCRX / Pacira BioSciences, Inc.
InstitutionFifth Third Bancorp
Latest Disclosed Ownership9,617 shares
Latest Disclosed Value $ 217,350
Fifth Third Bancorp reports 1,091.70% increase in ownership of PCRX / Pacira BioSciences, Inc.

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 9,617 shares of Pacira BioSciences, Inc. (US:PCRX) valued at $217,344 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 807 shares of Pacira BioSciences, Inc.. This represents a change in shares of 1,091.70% during the quarter. The current value of the position is $218,787 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F PACIRA BIOSCIENCES COM 695127100 9,617 8,810 1,091.70 217 985.00 0.0004
2026-02-02 2025-12-31 13F PACIRA BIOSCIENCES COM 695127100 807 6 0.75 21 0.00 0.0001
2025-11-07 2025-09-30 13F PACIRA BIOSCIENCES COM 695127100 801 -288 -26.45 21 -23.08 0.0001
2025-07-15 2025-06-30 13F PACIRA BIOSCIENCES COM 695127100 1,089 -514 -32.06 26 -33.33 0.0001
2025-04-15 2025-03-31 13F PACIRA BIOSCIENCES COM 695127100 1,603 48 3.09 40 34.48 0.0002
2025-01-21 2024-12-31 13F PACIRA BIOSCIENCES COM 695127100 1,555 -69 -4.25 29 20.83 0.0001
2024-10-17 2024-09-30 13F PACIRA BIOSCIENCES COM 695127100 1,624 1,354 501.48 24 242.86 0.0001
2024-07-22 2024-06-30 13F PACIRA BIOSCIENCES COM 695127100 270 -121 -30.95 8 -36.36 0.0000
2024-04-23 2024-03-31 13F PACIRA BIOSCIENCES COM 695127100 391 190 94.53 11 83.33 0.0000
2024-01-19 2023-12-31 13F PACIRA BIOSCIENCES COM 695127100 201 80 66.12 7 100.00 0.0000
2023-10-31 2023-09-30 13F PACIRA BIOSCIENCES COM 695127100 121 -612 -83.49 4 -89.66 0.0000
2023-07-26 2023-06-30 13F PACIRA BIOSCIENCES COM 695127100 733 253 52.71 29 52.63 0.0001
2023-04-24 2023-03-31 13F PACIRA BIOSCIENCES COM 695127100 480 276 135.29 20 171.43 0.0001
2023-01-25 2022-12-31 13F PACIRA BIOSCIENCES COM 695127100 204 -39 -16.05 8 -46.15 0.0000
2022-10-25 2022-09-30 13F PACIRA BIOSCIENCES COM 695127100 243 -69 -22.12 13 -27.78 0.0001
2022-08-04 2022-06-30 13F PACIRA BIOSCIENCES COM 695127100 312 -15 -4.59 18 -28.00 0.0001
2022-04-19 2022-03-31 13F PACIRA BIOSCIENCES COM 695127100 327 31 10.47 25 38.89 0.0001
2022-02-01 2021-12-31 13F PACIRA BIOSCIENCES COM 695127100 296 21 7.64 18 20.00 0.0001
2021-10-15 2021-09-30 13F PACIRA BIOSCIENCES COM 695127100 275 14 5.36 15 -6.25 0.0001
2021-08-06 2021-06-30 13F PACIRA BIOSCIENCES COM 695127100 261 -49 -15.81 16 -27.27 0.0001
2021-05-07 2021-03-31 13F PACIRA BIOSCIENCES COM 695127100 310 120 63.16 22 100.00 0.0001
2021-02-16 2020-12-31 13F PACIRA BIOSCIENCES COM 695127100 190 155 442.86 11 450.00 0.0001
2020-11-09 2020-09-30 13F PACIRA BIOSCIENCES COM 695127100 35 35 2 0.0000
2018-11-14 2018-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 0 -400 -100.00 0 -100.00
2018-08-14 2018-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 400 0 0.00 13 8.33 0.0001
2018-05-15 2018-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 400 0 0.00 12 -33.33 0.0001
2018-02-14 2017-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 400 -1,366 -77.35 18 -72.73 0.0001
2017-11-14 2017-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 1,766 -96 -5.16 66 -25.84 0.0005
2017-08-11 2017-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 1,862 39 2.14 89 7.23 0.0007
2017-05-12 2017-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 1,823 -62 -3.29 83 36.07 0.0006
2017-02-13 2016-12-31 13F/A-1 PACIRA PHARMACEUTICALS COM 695127100 1,885 -1,448 -43.44 61 -46.49 0.0005
2017-02-09 2016-12-31 13F PACIRA PHARMACEUTICALS COM 695127100 3,333 0 114 0.0009
2016-11-10 2016-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 3,333 2,036 156.98 114 159.09 0.0009
2016-08-11 2016-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 1,297 381 41.59 44 -10.20 0.0004
2016-05-13 2016-03-31 13F PACIRA PHARMACEUTICALS COM 695127100 916 916 0.00 49 0.0004
2015-11-13 2015-09-30 13F PACIRA PHARMACEUTICALS COM 695127100 0 -200 -100.00 0 -100.00
2015-08-14 2015-06-30 13F PACIRA PHARMACEUTICALS COM 695127100 200 200 14 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.